TOP2A and neoplasm: Additionally, H&E staining and immunohistochemistry of tumor tissues revealed disrupted tumor cell morphology, along with elevating the expression of cleaved caspase-3, γH2A.X, and TUNEL-positive cells, and decreasing the expression of TOP2A and the proliferation marker Ki67 in the treatment groups (Figure 7H).